Related references
Note: Only part of the references are listed.Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis
Jie Qing et al.
JOURNAL OF HEPATOLOGY (2022)
Mesenchymal stem cells ameliorate oxidative stress, inflammation, and hepatic fibrosis via Nrf2/HO-1 signaling pathway in rats
Sally M. Khadrawy et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
Cell therapy for advanced liver diseases: Repair or rebuild
Benjamin J. Dwyer et al.
JOURNAL OF HEPATOLOGY (2021)
The Hippo Pathway in Liver Homeostasis and Pathophysiology
Jordan H. Driskill et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Challenges and advances in clinical applications of mesenchymal stromal cells
Tian Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation
Zhen-ning Lu et al.
ACTA PHARMACOLOGICA SINICA (2021)
Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
Andreia Gomes et al.
CELL AND TISSUE RESEARCH (2021)
Liver cirrhosis
Pere Gines et al.
LANCET (2021)
New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis
Mingyao Sun et al.
PHARMACOLOGICAL RESEARCH (2021)
Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure
Oldouz Shareghi-oskoue et al.
STEM CELL RESEARCH & THERAPY (2021)
Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells
Yunqi Yao et al.
STEM CELL RESEARCH & THERAPY (2021)
Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF-β-WNT crosstalk
Tsukasa Kadota et al.
JOURNAL OF EXTRACELLULAR VESICLES (2021)
Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity
Jacques Galipeau
STEM CELLS (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice
Yasuhiro Nakano et al.
HEPATOLOGY (2020)
Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis
Meghan Mooring et al.
HEPATOLOGY (2020)
Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p
Mingyang Shao et al.
STEM CELL RESEARCH & THERAPY (2020)
Human Umbilical Cord-Derived Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome
Hon-Kan Yip et al.
CRITICAL CARE MEDICINE (2020)
Mesenchymal stromal cells; a new horizon in regenerative medicine
Shirin Tavakoli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Mesenchymal stromal cells promote liver regeneration through regulation of immune cells
Chenxia Hu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine
Ivan M. Moya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling
Jun Li et al.
EBIOMEDICINE (2019)
The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation
Li Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases
Chien-Wei Lee et al.
GASTROENTEROLOGY (2018)
Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury
S. Papa et al.
JOURNAL OF CONTROLLED RELEASE (2018)
A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis
Xueqing Fang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Mesenchymal-myeloid interaction in the regulation of immunity
Tik Shing Cheung et al.
SEMINARS IN IMMUNOLOGY (2018)
The Hippo Signaling Network and Its Biological Functions
Jyoti R. Misra et al.
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future
Ourania Trohatou et al.
CELLULAR REPROGRAMMING (2017)
The influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents?
F. Carty et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Transplantation With Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial
Ki Tae Suk et al.
HEPATOLOGY (2016)
Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche
Julianna Kobolak et al.
METHODS (2016)
LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development
Da-Hye Lee et al.
NATURE COMMUNICATIONS (2016)
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Inge Mannaerts et al.
JOURNAL OF HEPATOLOGY (2015)
Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer
Dean Yimlamai et al.
JOURNAL OF HEPATOLOGY (2015)
Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry
Blair W. Benham-Pyle et al.
SCIENCE (2015)
Adipose Tissue-Derived Stem Cells as a Regenerative Therapy for a Mouse Steatohepatitis-Induced Cirrhosis Model
Akihiro Seki et al.
HEPATOLOGY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Macrophages: Master Regulators of Inflammation and Fibrosis
Thomas A. Wynn et al.
SEMINARS IN LIVER DISEASE (2010)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Id1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells
E Wiercinska et al.
HEPATOLOGY (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1
A Swarbrick et al.
ONCOGENE (2005)
Share Paper
